LLY•benzinga•
As Race To Best 'Miracle' Obesity Drug Heats Up, Ozempic Maker Novo Nordisk Tests New Hybrid Drug That Can Reduce Weight Up To 25%
Summary
Novo's development chief, Martin Holst Lange, has shown optimism about the drug's promise, though he refrained from making any guarantees.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 4, 2024 by benzinga